Nowhere is the controversy over instrument upgrades more animated than in HPLC, or more correctly, in the debate over switching from HPLC to UHPLC.

Although by no means the only operational issue involved in HPLC, cost of ownership is something everyone considers and ultimately comes to grips with. 

Unlike many other mature analytical technologies, HPLC seems to have entered a period of intense innovation and competition. 

Adding steps to traditional method validation delivers higher ROI.

Consolidation, collaboration and configurability seem to be the three C’s driving the need for more tightly integrated lab workflows and systems, especially in the life science market. The challenge now is integrating data coming from many different sources and to decipher patterns that lead to insight and innovation.

Instrumentation lab plays key role in the University of Rochester's mission